Birch allergy shot study for eye symptoms
Part of Eyes & vision, Immune system & allergy clinical trials.
This trial tests a new antibody treatment for eye allergy symptoms caused by birch pollen. It may help if you have severe eye allergies during birch season.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a positive skin test for birch pollen
- You must have a positive blood test for birch and Bet v 1 allergy
- You must have had a certain level of eye allergy symptoms during a recent pollen season
- You cannot have other severe environmental allergies that could affect the study
- You cannot have eye diseases that might interfere with the results
- You cannot have had severe asthma requiring oral steroids more than twice in the last year
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an injectable treatment that may help manage eye allergy symptoms caused by cat allergies. It aims to see if the treatment is safe and effective for adults and children, and includes a controlled cat exposure challenge.
This study looks at how older adults (60+) with birch pollen allergies react to nasal allergen exposure. It compares people who currently have allergies, those who used to have them, and those who never did.
This trial tests an investigational eye drop called TL-925 to see if it can treat allergic conjunctivitis (eye allergies). If you have a history of eye allergies and a positive allergy skin test, you may be able to join.
This study looks at people with a birch pollen allergy to see how exposure in the nose can change allergy-related blood signals. The results may help explain why symptoms can “boost” throughout the body after nasal allergen contact.
This study is looking for adults and children aged 5 and older who have allergies to cats (Part A) and/or birch pollen (Part B). The goal is to better understand these allergies. If you are allergic to cats, you must not currently live with a cat and must not have lived with one in the past year.
This phase 3 trial tests a specific allergy treatment (an “immunotherapy” shot) for people whose symptoms are triggered by grass and cypress tree pollen. It aims to see if the treatment is safer and more effective at reducing allergy symptoms over time, especially for nose/eye symptoms and some people with asthma.
Hear when a new Allergic Conjunctivitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.